Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Risankizumab vs Adalimumab for Juvenile Psoriatic Arthritis
Recruiting2 awardsPhase 3
Cleveland, Ohio
This trial is studying the safety and effectiveness of a medication called risankizumab for the treatment of psoriatic arthritis in children. Psoriatic arthritis is a type of arthritis that causes joint
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.